— Contract Focused on Making DNA Data Storage Commercially Accessible — SAN FRANCISCO– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has been selected as a subcontractor to Georgia Tech Research Institute (GTRI) to undertake the DNA […]
SOUTH SAN FRANCISCO, Calif.–Jan. 15, 2020– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced today a collaboration with Schrödinger, Inc., a company focused on transforming the way therapeutics are discovered with a physics-based computational platform, to bring the two companies’ […]
Cambridge, United Kingdom – Congenica, a digital health company enabling rapid analysis of complex genomic data to improve disease characterization and diagnosis, today announced the launch of Congenica Neuro™, a new application on its clinical decision support platform that facilitates faster, more accurate and comprehensive characterization and diagnosis of epilepsy and neurodevelopmental disorders. Collectively, around 300 million people […]
BEVERLY, Mass. — seqWell has announced the close of a $9M Series B financing round with the goal of rapidly expanding its portfolio of genomics products into new areas such as single-cell genomics and transcriptomics. The company continues to drive its plexWell™ multiplexed library prep product offerings in growing markets such as high-throughput low-pass and targeted genotyping. […]
SureSeq™ CLL + CNV – comprehensive CLL genomic profiling from a single assay Oxford, UK – 14 January 2020. Oxford Gene Technology (OGT), A Sysmex Group Company, is excited to announce the launch of its SureSeq CLL + CNV Panel — the company’s latest high-quality, next-generation sequencing (NGS) offering for research into Chronic Lymphocytic Leukaemia (CLL). The SureSeq CLL + […]
Company continues to advance academic and industry access to precise CRISPR-based synthetic reagents for rapid clinical research and development across disease areas REDWOOD CITY, California – Synthego, the genome engineering company, today announced it has adopted Good Manufacturing Practice (GMP) standards to provide academic and industry partners with high-quality reagents for use in clinical research and development […]
ANN ARBOR, Mich. — Swift Biosciences, Inc. (“Swift”), a leader in design and manufacturing of unique DNA and RNA library preparation and normalization kits for Next-Generation Sequencing (NGS), and MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, today announced a co-marketing agreement for Swift’s DNA and RNA library preparation products in Europe and Asia Pacific markets. With […]
Next-generation gene editing system has applications in development of cell and gene therapies Base editing builds on CRISPR offering and will expand Horizon’s research tools and services Horizon seeks partners to assess and shape platform development Cambridge, UK, 14 January 2020: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global […]
BURLINGTON, N.C. & CARLSBAD, Calif.– LabCorp® (NYSE: LH) announced it will adopt the Ion Torrent Genexus System* and Oncomine Precision Assay* for use in research and development of companion diagnostics as well as other future oncology and precision medicine applications. LabCorp will also evaluate the potential for future deployment of the system and test across […]
Genomics England and Illumina today announced a new agreement to deliver up to 300,000 whole genome equivalents over the next five years, with an option to increase to 500,000. Samples will be provided through the NHS Genomic Medicine Service and the network of seven genomic laboratory hubs across England, which were established in 2018. This supports NHS England’s ambition […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
